Nektar Therapeutics Reports First Quarter 2022 Financial Results
Go back to Nektar Therapeutics Reports First Quarter 2022 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 73.58 -2.5 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.08 | 52 Week High | $19.98 | |||
| Open | $76.08 | 52 Week Low | $10.52 | |||
| Day High | $76.53 | P/E | N/A | |||
| Day Low | $73.19 | EPS | $-1.45 | |||
| Volume | 228,774 | |||||

